Omics approaches open new horizons in major depressive disorder: from biomarkers to precision medicine

Omics approaches open new horizons in major depressive disorder: from biomarkers to precision medicine

Major depressive disorder (MDD) is a recurrent episodic mood disorder that represents the third leading cause of disability worldwide. In MDD, several factors can simultaneously contribute to its development, which complicates its diagnosis. According to practical guidelines, antidepressants are the...

Full description

Bibliographic Details
Main Authors: Fabiola Stolfi, Hugo Abreu, Riccardo Sinella, Sara Nembrini, Sara Centonze, Virginia Landra, Claudio Brasso, Giuseppe Cappellano, Paola Rocca, Annalisa Chiocchetti
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-06-01
Series:Frontiers in Psychiatry
Subjects:
major depressive disorder
precision medicine
system biomedicine
biomarkers
antidepressant
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1422939/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1422939/full

Similar Items